Makmaul Laboratories Private Limited
About Makmaul Laboratories Private Limited
Data last updated:
Makmaul Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U00304DL2005PTC140231. Its GSTIN is 05AAECM5066H1ZI (Uttarakhand).
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹60 Lakh. It is led by directors Deepak Tayal and Priyanka Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 211 Sarja Marketmaharpur Sector 7 Rohini Delhi, Delhi, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.62 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.4 Lakh (net margin 0.9%) and EBITDA of ₹62.26 Lakh (EBITDA margin 23.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹4.23 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Makmaul Laboratories Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address211 Sarja Marketmaharpur Sector 7 Rohini Delhi, Delhi, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Makmaul Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Makmaul Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Makmaul Laboratories Private Limited, buy the company report.
Financials of Makmaul Laboratories Private Limited
FY 2024 filings availableMakmaul Laboratories Private Limited reported revenue of ₹2.62 Cr (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 10% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.8% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Makmaul Laboratories Private Limited, buy the company report.
Board of directors of Makmaul Laboratories Private Limited
Makmaul Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Tayal | Director | 31 Aug 2005 | 21 Years 1 Months | Current |
| Priyanka Agrawal | Director | 19 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Makmaul Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Makmaul Laboratories Private Limitedthis company | ₹2.62 Cr (FY 2024) | ₹2.4 Lakh | 0.9% | -10.0% | Delhi, India | |
| Kriven Health Solutions Private Limited | ₹2.61 Cr (FY 2025) | 1162.0% | Lucknow, Uttar Pradesh, India | |||
| Zenobio Life Sciences Private Limited | ₹2.61 Cr (FY 2024) | 2.0% | Ahmedabad, Gujarat, India | |||
| BGP Laboratories Private Limited | ₹2.6 Cr (FY 2025) | 183.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Makmaul Laboratories Private Limited, buy the company report.
Auditor
Makmaul Laboratories Private Limited is audited by ASHOK DARSHAN & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK DARSHAN & CO | FY 2021 | 015886N |
Shareholding
The shareholding of Makmaul Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Makmaul Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2021 | 100519604 | Others | ₹23.5 Lakh | Open | |
| 10 Aug 2020 | 100378644 | Others | ₹46 Lakh | Open | |
| 06 Dec 2006 | 10032882 | Others | ₹3.53 Cr | Open |
To see the full charge records of Makmaul Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Makmaul Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Makmaul Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Makmaul Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Makmaul Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECM5066H1ZI | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Makmaul Laboratories Private Limited, buy the company report.
Recent activity
Makmaul Laboratories Private Limited has 6 board changes on record since 2005: 2 appointments and 4 cessations. The latest: Sumesh Mittal ceased to be Additional Director on 05 Dec 2014.
1 earlier event is in the company report.
Frequently asked questions
Makmaul Laboratories is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2005 (21+ years old) and is registered under CIN U00304DL2005PTC140231.
Makmaul Laboratories has 2 current directors:
- Deepak Tayal - Director
- Priyanka Agrawal - Director
The latest financial statements of Makmaul Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Makmaul Laboratories is 05AAECM5066H1ZI, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Makmaul Laboratories is U00304DL2005PTC140231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Makmaul Laboratories has 1 court case on record: 1 filed against it.
Makmaul Laboratories was incorporated on 31 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Makmaul Laboratories by revenue are Kriven Health Solutions Private Limited, Zenobio Life Sciences Private Limited, BGP Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sumesh Mittal ceased to be Additional Director on 05 Dec 2014. Priyanka Agrawal was appointed as Director on 19 Jul 2014. Lalit Kumar ceased to be Director on 06 Sep 2011. Makmaul Laboratories has 6 board changes on record in total.
The registered office of Makmaul Laboratories is at 211 Sarja Marketmaharpur Sector 7 Rohini Delhi, Delhi, India.
Makmaul Laboratories operates in the pharma industry, in the drug formulation and development segment.